Clinical Trials Browser

Phase 3 × Withdrawn × Neoplasm Metastasis × Clear all

Brain Neoplasms, Breast Neoplasms, Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Triple Negative Breast Neoplasms

NCT04465734 2022-05-05

A Clinical Study to Compare the Efficacy and Safety of HLX10 in Combination With HLX04 Versus Sorafenib as the First-line Treatment in Patients With Locally Advanced or Metastatic HCC

Phase 3 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasm Metastasis

NCT03811418 2019-11-26

ATTILA

Phase 3 Withdrawn

Tumor-Agnostic

Neoplasm Metastasis

NCT02929576 2018-10-22

ENDEAR

Phase 3 Withdrawn

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01169129 2014-02-04

Surgery and Whole Brain Radiotherapy (RT) Versus Whole Brain Radiotherapy (RT) and Radiosurgery for 1-3 Resectable Brain Metastases

Phase 3 Withdrawn

CNS

Brain Neoplasms, Neoplasm Metastasis, Neoplasms

NCT00301886 2013-11-13

S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone

Phase 3 Withdrawn

Breast

Humoral Hypercalcemia Of Malignancy, Breast Neoplasms, Neoplasm Metastasis, Pain

Clinical Trials

METRICS

A Clinical Study to Compare the Efficacy and Safety of HLX10 in Combination With HLX04 Versus Sorafenib as the First-line Treatment in Patients With Locally Advanced or Metastatic HCC

ATTILA

ENDEAR

Surgery and Whole Brain Radiotherapy (RT) Versus Whole Brain Radiotherapy (RT) and Radiosurgery for 1-3 Resectable Brain Metastases

S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone